Immune cells in the brain react to synuclein clumps ratcheting up the inflammasome in Parkinsons disease. Read our story on how drug makers aim to disrupt it httpswww.nature.comarticlesd41587019000058Âpic.twitter.coma31xqcPM6G

Immune cells in the brain react to α-synuclein clumps, ratcheting up the inflammasome in #Parkinsons disease. Read our story on how drug makers aim to disrupt it https://www.nature.com/articles/d41587-019-00005-8 …pic.twitter.com/a31xqcPM6G

14:05 EST 22 Jan 2019 | Nature Publishing

Immune cells in the brain react to α-synuclein clumps, ratcheting up the inflammasome in #Parkinsons disease. Read our story on how drug makers aim to disrupt it https://www.nature.com/articles/d41587-019-00005-8 … pic.twitter.com/a31xqcPM6G

More From BioPortfolio on "Immune cells in the brain react to α-synuclein clumps, ratcheting up the inflammasome in #Parkinsons disease. Read our story on how drug makers aim to disrupt it https://www.nature.com/articles/d41587-019-00005-8 …pic.twitter.com/a31xqcPM6G"